The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
- Nicholas R. Anthonisen, MD;
- Melissa A. Skeans, MS;
- Robert A. Wise, MD;
- Jure Manfreda, MD;
- Richard E. Kanner, MD;
- John E. Connett, PhD; and
- for the Lung Health Study Research Group*
-
From University of Manitoba, Winnipeg, Manitoba, Canada; University of Minnesota, Minneapolis, Minnesota; Johns Hopkins University,
Baltimore, Maryland; and University of Utah, Salt Lake City, Utah.
-
Figure 1. 461 of 3923 patients died in the special intervention group vs. 270 of 1964 patients in the usual care group ( =
0.031, log-rank test). LHS = Lung Health Study. All-cause 14.5-year survival.P
-
Figure 2. The only significant difference was in respiratory disease other than lung cancer (log-rank test). CHD = coronary
heart disease; CVD = cardiovascular disease. Mortality rates at 14.5 years by cause.
-
Figure 3. Rates were significantly different for coronary heart disease ( ), cardiovascular disease ( ), lung cancer, and
other causes of death (log-rank test). Mortality rates at 14.5 years by cause and smoking status.CHDCVD
Responses to this article
-
Ann Intern Med
February 15, 2005
vol. 142
no. 4
233-239
RSS Feeds
View larger version:Figure 1. 461 of 3923 patients died in the special intervention group vs. 270 of 1964 patients in the usual care group ( = 0.031, log-rank test). LHS = Lung Health Study. All-cause 14.5-year survival.P
View larger version:Figure 2. The only significant difference was in respiratory disease other than lung cancer (log-rank test). CHD = coronary heart disease; CVD = cardiovascular disease. Mortality rates at 14.5 years by cause.
View larger version:Figure 3. Rates were significantly different for coronary heart disease ( ), cardiovascular disease ( ), lung cancer, and other causes of death (log-rank test). Mortality rates at 14.5 years by cause and smoking status.CHDCVD
Related Clinical Content
